Risk factors for SVT
| Risk factors . |
|---|
| Abdominal disorders and interventions |
| Acute |
| Pancreatitis |
| Peritonitis and intraabdominal sepsis |
| Inflammatory bowel disease |
| Diverticulitis |
| Hydatidosis |
| Splenectomy |
| General abdominal surgery |
| Sclerotherapy for esophageal varices |
| Abdominal trauma |
| Chronic |
| Cirrhosis |
| Abdominal cancer |
| Portal hypertension |
| Hematological disorders |
| Philadelphia chromosome negative chronic MPNs |
| Polycythemia vera |
| Essential thrombocythemia |
| Idiopathic myelofibrosis |
| PNH |
| Inherited thrombophilic state |
| Antithrombin deficiency |
| Protein C deficiency |
| Protein S deficiency |
| Factor V Leiden |
| G20210A mutation in prothrombin gene |
| Antiphospholipid syndrome |
| Hormones |
| Oral contraceptives |
| Hormonal replacement therapy |
| Pregnancy |
| Puerperium |
| Virus |
| Cytomegalovirus |
| Autoimmune disorders |
| Behçet's disease |
| Hypereosinophilic syndrome |
| Other |
| Membranous webs |
| New biological marker of subclinical disorders |
| JAK2V617 mutation |
| Risk factors . |
|---|
| Abdominal disorders and interventions |
| Acute |
| Pancreatitis |
| Peritonitis and intraabdominal sepsis |
| Inflammatory bowel disease |
| Diverticulitis |
| Hydatidosis |
| Splenectomy |
| General abdominal surgery |
| Sclerotherapy for esophageal varices |
| Abdominal trauma |
| Chronic |
| Cirrhosis |
| Abdominal cancer |
| Portal hypertension |
| Hematological disorders |
| Philadelphia chromosome negative chronic MPNs |
| Polycythemia vera |
| Essential thrombocythemia |
| Idiopathic myelofibrosis |
| PNH |
| Inherited thrombophilic state |
| Antithrombin deficiency |
| Protein C deficiency |
| Protein S deficiency |
| Factor V Leiden |
| G20210A mutation in prothrombin gene |
| Antiphospholipid syndrome |
| Hormones |
| Oral contraceptives |
| Hormonal replacement therapy |
| Pregnancy |
| Puerperium |
| Virus |
| Cytomegalovirus |
| Autoimmune disorders |
| Behçet's disease |
| Hypereosinophilic syndrome |
| Other |
| Membranous webs |
| New biological marker of subclinical disorders |
| JAK2V617 mutation |